Evolent Health Inc - Ordinary Shares - Class A
EVH
Market Cap$2.6B
Close$
$-18.85
187% downside
Current Fair Value
187% downsideOvervalued by 187% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.60 Billion |
|---|---|
| Enterprise Value | $3.01 Billion |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-1.28 |
| Beta | 0.0 |
| Outstanding Shares | 116,213,123 |
| Avg 30 Day Volume | 1,637,810 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -18.31 |
|---|---|
| PEG | -6.91 |
| Price to Sales | 1.35 |
| Price to Book Ratio | 2.17 |
| Enterprise Value to Revenue | 1.53 |
| Enterprise Value to EBIT | -152.22 |
| Enterprise Value to Net Income | -22 |
| Total Debt to Enterprise | 0.2 |
| Debt to Equity | 0.48 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Evolent Health Inc
CEO: Frank Williams